Showing results (211-220 of 2,345) with videos related to
Sort By:
Pageof 235
The AAPS Journal|February 27, 2019
A Density-Changing Centrifugation Method for Efficient Separation of Free Drugs from Drug-Loaded Particulate Delivery SystemsLu Han, Hongyan Zhan, Xun Sun, et al.The AAPS Journal|March 10, 2011
Use of a local sensitivity analysis to inform study design based on a mechanistic toxicokinetic model for γ-hydroxybutyric acidMelanie A Felmlee, Wojciech Krzyzanski, Bridget L Morse, et al.The AAPS Journal|March 10, 2011
Evaluation of α2-integrin expression as a biomarker for tumor growth inhibition for the investigational integrin inhibitor E7820 in preclinical and clinical studiesRon J Keizer, Y Funahashi, T Semba, et al.The AAPS Journal|March 8, 2011
Summary of confirmation cut point discussionsHolly W Smith, Michael Moxness, Robin MarsdenThe AAPS Journal|March 26, 2011
Pharmacodynamic model of parathyroid hormone modulation by a negative allosteric modulator of the calcium-sensing receptorAnson K Abraham, Tristan S Maurer, Amit S Kalgutkar, et al.The AAPS Journal|April 5, 2011
Assessment of incurred sample reanalysis for macromolecules to evaluate bioanalytical method robustness: effects from imprecisionTheingi M Thway, Michael Eschenberg, Dominador Calamba, et al.The AAPS Journal|June 2, 2011
AAPS workshop report: strategies to address therapeutic protein-drug interactions during clinical developmentSandhya Girish, Steven W Martin, Mark C Peterson, et al.The AAPS Journal|May 4, 2011
Resistance to the translation initiation inhibitor silvestrol is mediated by ABCB1/P-glycoprotein overexpression in acute lymphoblastic leukemia cellsSneha V Gupta, Ellen J Sass, Melanie E Davis, et al.The AAPS Journal|April 16, 2011
Synthesis and pharmacological evaluation of 6-acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79), a cocaine antagonist, in rodentsNidhi Kaushal, Matthew J Robson, Harsha Vinnakota, et al.The AAPS Journal|June 15, 2011
Vaccinomics: current findings, challenges and novel approaches for vaccine developmentInna G Ovsyannikova, Gregory A PolandPageof 235